Maven Securities LTD Vertex Pharmaceuticals Inc Transaction History

Maven Securities LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$221.42 - $260.97 $794,454 - $936,360	-3,588 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$177.01 - $223.45 $635,111 - $801,738	3,588 New	3,588 $788,000
Q2 2021 Aug 16, 2021	SELL	$187.49 - $221.1 $811,456 - $956,920	-4,328 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$207.02 - $241.31 $109,306 - $127,411	528 Added 13.89%	4,328 $931,000
Q4 2020 Feb 12, 2021	BUY	$207.01 - $276.09 $157,948 - $210,656	763 Added 25.12%	3,800 $898,000

Q3 2020 Nov 13, 2020	BUY	$255.65 - $303.1 $583,648 - $691,977	2,283 Added 302.79%	3,037 $830,000
Q2 2020 Aug 14, 2020	SELL	$225.48 - $295.8 $145,660 - $191,086	-646 Reduced 46.14%	754 $219,000
Q1 2020 May 15, 2020	BUY	$199.77 - $247.81 $279,678 - $346,934	1,400 New	1,400 $333,000

1,624

222M

1.35M

1.49M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $121B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

Stay updated on Maven Securities LTD with notifications on news.